NCT03259503 2025-11-10Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell TransplantM.D. Anderson Cancer CenterPhase 1 Completed50 enrolled
NCT03742258 2025-06-18Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell LymphomaNorthwestern UniversityPhase 1 Completed12 enrolled 13 charts